ArticleGynecologic oncology case reports2012
Prolonged response of relapsed high grade serous ovarian carcinoma to the oral angiokinase inhibitor nintedanib in a patient with a germline BRCA1 mutation.
Han Hsi Wong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.